Clinical Trials Logo

Atypical Femoral Fracture clinical trials

View clinical trials related to Atypical Femoral Fracture.

Filter by:
  • None
  • Page 1

NCT ID: NCT01705587 Completed - Osteoporosis Clinical Trials

Fracture (FX) Improvement With Teriparatide: FiX-IT Study

FiX-IT
Start date: December 2012
Phase: Phase 4
Study type: Interventional

This open label comparison study examines the hypothesis that teriparatide given immediately following repair of an atypical subtrochanteric or diaphyseal femoral shaft fracture will enhance healing and improve bone mineral density compared to delayed treatment (after six months) with teriparatide or no treatment with teriparatide (patients who refuse therapy or for whom teriparatide is contraindicated). Patients with up-front teriparatide in addition will have greater quality of life measures and less pain compared to those with delayed or no therapy.